Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Construction of a Machine Learning-Based Clopidogrel Resistance Risk Prediction Model.

Cardiovascular toxicology - 1 Oct 2025

Wang Ruo-Ying, Yan Shui-Di, Zeng Jian-Qi, Mu Tong, Yan Ya, Zhao Yuan-Yi, Xie Lin, Liu Li-Li

Abstract excerpt

Clopidogrel is extensively utilized for the prevention and treatment of cardiovascular, cerebrovascular, and other arterial circulation disorders attributed to platelet hyperaggregation. Nevertheless, its antiplatelet efficacy displays substantial individual variability and unpredictability. Our aim was to develop a machine learning model based on clinical data, incorporating various laboratory indicators, to...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Clinical Decision-Making
Share to Clopidogrel

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cytochrome P-450 CYP2C19

Share to Decision Support Techniques

Share to Machine Learning

Share to Pharmacogenomic Variants

Share to Platelet Aggregation

Share to Platelet Aggregation Inhibitors

Source

Identifiers

PMID: 40658305
DOI: 10.1007/s12012-025-10026-2

Genes

CYP2C19

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Construction of a Machine Learning-Based Clopidogrel Resistance Risk Prediction Model.PMID 40658305Read ↗

The polygenic implication of clopidogrel responsiveness: Insights from platelet reactivity analysis and next-generation sequencing.Semantic proximity Read ↗

Relationship between CYP2C19 Polymorphism and Clopidogrel Resistance in Patients with Coronary Heart Disease and Ischemic Stroke in China.Semantic proximity Read ↗

Development and Preliminary Assessment of a Mortality Risk Score in Patients with Coronary Artery Disease Receiving Dual Antiplatelet Therapy After Percutaneous Coronary InterventionSemantic proximity Read ↗

[Effects of clopidogrel resistence and CYP2C19 genotype on the clinical prognosis of patients with acute coronary syndrome undergoing percutaneous coronary intervention].Semantic proximity Read ↗

Association of P2Y12 G52T genetic polymorphism with recurrent thromboembolic events in stroke and myocardial infarction patients on clopidogrel therapy: a prospective observational study.Semantic proximity Read ↗

2025 Acute Coronary Syndrome Guideline: Missing the Boat on CYP2C19 Genotyping.Semantic proximity Read ↗

The correlation between platelet responsiveness to clopidogrel and CYP2C19 polymorphism in patients with peripheral vascular disease.Semantic proximity Read ↗

Optimizing P2Y12 Inhibitor Therapy in Post-PCI Patients Through Genotype-Guided Strategies: A Systematic Review and Meta-Analysis.Semantic proximity Read ↗

Pharmacogenetics of clopidogrel and warfarin in the treatment of cardiovascular diseases: an overview of reviews.Semantic proximity Read ↗

Clinical, pharmacokinetic, and pharmacogenetic determinants of clopidogrel resistance in Korean patients with acute coronary syndrome.Semantic proximity Read ↗

Development and Validation of a Rapid Point-of-Care CYP2C19 Genotyping PlatformSemantic proximity Read ↗

Evaluating the Effect of Estimating Renal Function With the CKD-EPI 2021 Equation on the ABCD-GENE Score for Clopidogrel Response Prediction.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.